Cargando…

Breast cancer stem cell markers CD44 and ALDH1A1 in serum: distribution and prognostic value in patients with primary breast cancer

Background: CD44 and ALDH1 have been recognized as the most widely used markers to identify breast cancer stem cells (BCSCs). However, limited to tissue sample and rare population, BCSCs have always been not easily detected. We aimed to measure CD44 and ALDH1A1 (major contributor to ALDH1 activity)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kong, Yanan, Lyu, Ning, Wu, Jiali, Tang, Hailin, Xie, Xinhua, Yang, Lu, Li, Xing, Wei, Weidong, Xie, Xiaoming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215997/ https://www.ncbi.nlm.nih.gov/pubmed/30405844 http://dx.doi.org/10.7150/jca.28032

Ejemplares similares

circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression
por: Chen, Bo, et al.
Publicado: (2018)

Evaluation of STAT3 Signaling in ALDH+ and ALDH+/CD44+/CD24− Subpopulations of Breast Cancer Cells
por: Lin, Li, et al.
Publicado: (2013)

Expression of Androgen Receptor and Cancer Stem Cell Markers (CD44(+)/CD24(−) and ALDH1(+)): Prognostic Implications in Invasive Breast Cancer()()
por: Riaz, Nazia, et al.
Publicado: (2018)

Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 as a Prognostic Indicator in Breast Cancer Patients with Distant Metastases
por: Horimoto, Yoshiya, et al.
Publicado: (2016)

Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
por: Li, Wenzhe, et al.
Publicado: (2017)

Linc01638 Promotes Tumorigenesis in HER2+ Breast Cancer
por: Liu, Peng, et al.
Publicado: (2019)

Prognostic Value of Cancer Stem Cell Markers CD44 and ALDH1/2 in Gastric Cancer Cases
por: Senel, Fatma, et al.
Publicado: (2017)

Hepatitis B virus infection specially increases risk of liver metastasis in breast cancer patients: a propensity-matched analysis
por: Yu, Ping, et al.
Publicado: (2020)

Knockdown of ALDH1A3 reduces breast cancer stem cell marker CD44 via the miR-7-TGFBR2-Smad3-CD44 regulatory axis
por: Pan, Meng, et al.
Publicado: (2021)

Author Correction: Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
por: Li, Wenzhe, et al.
Publicado: (2018)

Cancer stem cell markers ALDH1 and CD44+/CD24– phenotype and their prognosis impact in invasive ductal carcinoma
por: Rabinovich, Iris, et al.
Publicado: (2018)

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer
por: Lugli, A, et al.
Publicado: (2010)

Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer
por: Heerma van Voss, Marise R., et al.
Publicado: (2011)

Role of cancer stem cell markers ALDH1, BCL11B, BMI-1, and CD44 in the prognosis of advanced HNSCC
por: Jakob, Mark, et al.
Publicado: (2020)

The combination of aldehyde dehydrogenase 1 (ALDH1) and CD44 is associated with poor outcomes in endometrial cancer
por: Huang, Hsin-Hui, et al.
Publicado: (2018)

Prognostic significance of preoperative serum inflammation markers in patients with male breast cancer
por: Li, Xing, et al.
Publicado: (2021)

SOX2 Promotes Brain Metastasis of Breast Cancer by Upregulating the Expression of FSCN1 and HBEGF
por: Xiao, Weikai, et al.
Publicado: (2020)

Melatonin Regulates Breast Cancer Progression by the lnc010561/miR-30/FKBP3 Axis
por: Liu, Peng, et al.
Publicado: (2019)

Aldehyde dehydrogenase 1 (ALDH1) immunostaining in axillary lymph node metastases is an independent prognostic factor in ALDH1-positive breast cancer
por: Guan, Xin, et al.
Publicado: (2021)

Nomogram to Predict Internal Mammary Lymph Nodes Metastasis in Patients With Breast Cancer
por: Xie, Xinhua, et al.
Publicado: (2019)

CircAHNAK1 inhibits proliferation and metastasis of triple-negative breast cancer by modulating miR-421 and RASA1
por: Xiao, Weikai, et al.
Publicado: (2019)

Discrimination of Cancer Stem Cell Markers ALDH1A1, BCL11B, BMI-1, and CD44 in Different Tissues of HNSCC Patients
por: Sharaf, Kariem, et al.
Publicado: (2021)

ALDH1 Cancer Stem Cell Marker as a Prognostic Factor in Triple-Negative Breast Cancer
por: Panigoro, Sonar Soni, et al.
Publicado: (2020)

Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer
por: WANG, CHUNXIA, et al.
Publicado: (2012)

mir-101-3p is a key regulator of tumor metabolism in triple negative breast cancer targeting AMPK
por: Liu, Peng, et al.
Publicado: (2016)

Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer
por: Kim, Sung Jeep, et al.
Publicado: (2015)

MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1
por: Gao, Jie, et al.
Publicado: (2013)

Prognostic Significance of TWIST1, CD24, CD44, and ALDH1 Transcript Quantification in EpCAM-Positive Circulating Tumor Cells from Early Stage Breast Cancer Patients
por: Strati, Areti, et al.
Publicado: (2019)

Evaluation of ALDH1 expression in ipsilateral breast cancer recurrence
por: Shien, Tadahiko, et al.
Publicado: (2017)

The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression—ALDH1A1, CD133, CD44—For Survival and Long-Term Follow-Up of Ovarian Cancer Patients
por: Izycka, Natalia, et al.
Publicado: (2023)

AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer
por: Zhang, Kaiming, et al.
Publicado: (2018)

Correction: MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1
por: Gao, Jie, et al.
Publicado: (2013)

Epidermal growth factor receptor in breast carcinoma: association between gene copy number and mutations
por: Lv, Ning, et al.
Publicado: (2011)

ALDH1+ stem cells demonstrate more stem cell-like characteristics than CD44(+)/CD24(–/low) stem cells in different molecular subtypes of breast cancer
por: Chen, Jie, et al.
Publicado: (2020)

Corrigendum: AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer
por: Zhang, Kaiming, et al.
Publicado: (2020)

Diagnostic and prognostic value of serum MACC1 in breast cancer patients
por: Tan, Weige, et al.
Publicado: (2016)

Comments on the "Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer"
por: Ieni, Antonio, et al.
Publicado: (2016)

Is surgical axillary staging necessary in women with T1 breast cancer who are treated with breast-conserving therapy?
por: Wang, Jin, et al.
Publicado: (2019)

Metformin mediates induction of miR‐708 to inhibit self‐renewal and chemoresistance of breast cancer stem cells through targeting CD47
por: Tan, Weige, et al.
Publicado: (2019)

Identification of a 4‐mRNA metastasis‐related prognostic signature for patients with breast cancer
por: Xie, Xinhua, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_o4bhn6qlthptctpbbv7rv114sd